Switching to tirzepatide linked to additional reduction in HbA1c, weight loss compared with escalating dulaglutide.

Patients with type 2 diabetes who switched to tirzepatide rather than escalating their dulaglutide dosage had greater weight ...

Diabetes patients on dulaglutide (Trulicity) had better glycemic control and more weight loss if they switched to tirzepatide ...

For patients with inadequately controlled type 2 diabetes receiving dulaglutide, switching to tirzepatide is associated with additional hemoglobin A1c (HbA1c) reduction and weight loss compared with ...

The following is a summary of “Low-moderate alcohol use effects on glycemic control of patients presenting in the ED,” ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

A new study has found that patients with type 2 diabetes who are not reaching their blood sugar goals on dulaglutide can ...

The rise of GLP-1s, which were initially approved for diabetes management and later for obesity treatment, underscores this ...

HbA1c isn’t just a number to glance at, compare to standard levels, and decide if someone is diabetic. While that’s often what we do when reviewing a blood sugar profile, the story behind this ...

Neoadjuvant semaglutide showed no benefit in weight loss, diabetes remission or safety in a cohort of patients who underwent ...